Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,751,562
  • Shares Outstanding, K 111,092
  • Annual Sales, $ 9,252 M
  • Annual Income, $ 854,000 K
  • 60-Month Beta 0.89
  • Price/Sales 1.83
  • Price/Cash Flow 11.94
  • Price/Book 2.54
Trade DGX with:

Options Overview Details

View History
  • Implied Volatility 24.58% ( +0.37%)
  • Historical Volatility 12.42%
  • IV Percentile 92%
  • IV Rank 71.11%
  • IV High 28.33% on 08/05/24
  • IV Low 15.34% on 11/22/23
  • Put/Call Vol Ratio 1.21
  • Today's Volume 373
  • Volume Avg (30-Day) 237
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 8,298
  • Open Int (30-Day) 8,449

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 2.26
  • Number of Estimates 10
  • High Estimate 2.32
  • Low Estimate 2.22
  • Prior Year 2.22
  • Growth Rate Est. (year over year) +1.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
149.52 +0.85%
on 09/11/24
157.23 -4.10%
on 09/16/24
-4.60 (-2.96%)
since 09/04/24
3-Month
136.99 +10.07%
on 07/09/24
159.36 -5.38%
on 09/04/24
+9.89 (+7.02%)
since 07/03/24
52-Week
120.10 +25.55%
on 10/12/23
159.36 -5.38%
on 09/04/24
+28.21 (+23.01%)
since 10/04/23

Most Recent Stories

More News
Reasons to Add Baxter International Stock to Your Portfolio Now

Baxter International BAX is poised for growth, given the demand for its medically essential products, coupled with transformational actions. However, inflationary pressure remains a concern.Shares of this...

UHS : 215.68 (+0.24%)
DGX : 150.79 (-0.39%)
BSX : 84.54 (+0.86%)
BAX : 36.32 (+3.53%)
Quest Diagnostics' Quarterly Earnings Preview: What You Need to Know

With Quest Diagnostics gearing up to release its third-quarter earnings later this month, analysts expect a low single-digit earnings growth.

XLV : 151.64 (+0.08%)
DGX : 150.79 (-0.39%)
$SPX : 5,751.07 (+0.90%)
Stryker Stock Gains 18.6% YTD: What's Driving its Share Price?

Stryker Corporation SYK has witnessed substantial gains in the year-to-date period. Shares of the company have rallied 18.6% compared with 13.4% growth of the industry. The S&P 500 Composite has risen...

UHS : 215.68 (+0.24%)
DGX : 150.79 (-0.39%)
SYK : 351.22 (-0.11%)
BAX : 36.32 (+3.53%)
FMS Stock Rides on Diversified Portfolio and Restructuring Initiatives

Fresenius Medical Care FMS is one of the largest integrated providers of products and services for individuals undergoing dialysis following chronic kidney failure. Through its network of more than 3,600...

UHS : 215.68 (+0.24%)
DGX : 150.79 (-0.39%)
BAX : 36.32 (+3.53%)
FMS : 20.70 (-0.24%)
How Is Labcorp Holdings’ Stock Performance Compared to Other Healthcare Stocks?

Labcorp Holdings recently outperformed the healthcare sector peers, and Wall Street analysts are moderately optimistic about the stock’s prospects.

XHS : 94.01 (+0.63%)
DGX : 150.79 (-0.39%)
LH : 216.00 (+0.43%)
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector?

Quest Diagnostics has outperformed the broader healthcare sector recently, and analysts are bullish about the stock's future.

XLV : 151.64 (+0.08%)
DGX : 150.79 (-0.39%)
TMO : 598.61 (-0.38%)
Factors Driving Veeva Stock More Than 20% in Three Months

Shares of Veeva Systems VEEV have risen 20.5% in the past three months, outperforming both the industry as well as the S&P 500 Index. The outperformance was primarily driven by its strong quarterly results...

BSX : 84.54 (+0.86%)
DGX : 150.79 (-0.39%)
DVA : 160.69 (+1.02%)
VEEV : 204.67 (+0.07%)
SYK Stocks Gains Following Expansion of Foot & Ankle Portfolio

Stryker SYK recently announced the expansion of its Foot & Ankle portfolio with the introduction of two cutting-edge products — the Osteotomy Truss System (“OTS”) and the Ankle Truss System (“ATS”)....

BSX : 84.54 (+0.86%)
DGX : 150.79 (-0.39%)
SYK : 351.22 (-0.11%)
DVA : 160.69 (+1.02%)
VEEV Stock Up Following the Release of New Features of Veeva Site Connect

Veeva Systems Inc. VEEV recently announced the newest release of Veeva Site Connect. The release adds powerful new capabilities and a streamlined site-centric experience to simplify and standardize sponsor-site...

BSX : 84.54 (+0.86%)
DGX : 150.79 (-0.39%)
DVA : 160.69 (+1.02%)
VEEV : 204.67 (+0.07%)
COO Stock Up 0.4% Following the Launch of New Inserter for Paragard IUD

The Cooper Companies, Inc.’s COO business segment, CooperSurgical (CSI), announced the launch of a new inserter designed for single-hand placement of Paragard on Tuesday, which was recently approved...

BSX : 84.54 (+0.86%)
DGX : 150.79 (-0.39%)
DVA : 160.69 (+1.02%)
COO : 105.92 (-0.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 154.12
2nd Resistance Point 153.30
1st Resistance Point 152.05
Last Price 150.79
1st Support Level 149.98
2nd Support Level 149.16
3rd Support Level 147.91

See More

52-Week High 159.36
Last Price 150.79
Fibonacci 61.8% 144.36
Fibonacci 50% 139.73
Fibonacci 38.2% 135.10
52-Week Low 120.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar